ABSTRACT
Oral squamous cell carcinoma (OSCC) accounts for more than 90% of oral cancers (occurring in the mouth, lip, and tongue) and is the eighth most common cancer in humans. OSCC accounts for approximately 2.5% of all new cancer cases and 1.9% of all cancer deaths annually. 1, 2 Many important risk factors have been identified so far for OSCC, including immune status, smoking, alcohol use, and the synergistic effects of tobacco and alcohol. 1, 3 Despite recent advances in cancer treatment methods, the 5-year survival rate of OSCC is approximately 50% in the advanced stage of the disease. 4, 5 Although there are conventional tumor parameters, such as tumor size, nodal status, and the existence of systemic metastasis, new molecular markers are warranted to provide more information on the tumor biology, to allow a better prognosis and possibly predict the stratification of patients.
Golgi phosphoprotein 2 (GOLPH2), also known as Golgi membrane protein 1 (GOLM1) or GP73, is a Golgi phosphoprotein of yet unknown function. The 73-kDa Golgi apparatus-associated protein is encoded by the GOLM1 gene and was first described in the liver tissue of a patient with giant cell hepatitis. 6 The structure includes several areas of possible glycosylation. 7 Due to its localization at the Golgi apparatus, the proposed functions include protein modification, cell signaling, intracellular transport function, or merely local structural tasks. 8 Initially, GOLPH2 upregulation was reported in neoplastic and nonneoplastic liver pathologies, and many studies postulated that its serum level is a novel marker of hepatocellular carcinoma. 9 Subsequently, enhanced GOLPH2 expression was reported in other cancer settings such as GOLPH2 has been implicated in several important pathologic processes, including cancer cell proliferation and metastasis. 15, 16 The epithelial-mesenchymal transition (EMT) is a process by which epithelial cells lose their cell polarity and cell-cell adhesion and is a key developmental program that is often activated during cancer invasion and metastasis. 17 Cancer stem cells (CSCs) represent a minor subpopulation of tumor cells that share some features with the normal stem cells of the tissue from which tumor derives and have the properties of self-renewal, multiple differentiations, and tumor initiation. 18 CSCs cause relapse and metastasis by giving rise to new tumors and are therefore tumorigenic in contrast to other nontumorigenic cancer cells. 19 This property conferred by the EMT is thus a doubly dangerous duo for the patient, as it not only enables the carcinoma cells to enter the bloodstream but also increases the tumorigenic and proliferative potential of these cells. 20 CD44, SOX2 and Slug, the marker of CSCs and EMT, were correlated with OSCC in previous studies. [21] [22] [23] The immune system plays a key role in the development, establishment, and progression of cancer. 24 In a recent study, GOLPH2 was proved to have a correlation with the immune system and be a novel regulator of interleukin 12 production and macrophage polarization. 16 Immune checkpoint pathways can be coopted by cancer to evade immune destruction, particularly targeting T cells. 25 In our previous studies, we demonstrated the expression status of B7-H3, B7-H4, TIM3, and VISTA, four of the inhibitory immune checkpoints in OSCC, [26] [27] [28] [29] but the correlation between GOLPH2 and immune checkpoint was unclear.
Although the expression of GOLPH2 has been studied in several types of cancer, the association between GOLPH2 and OSCC remains unknown. The central aim of this study was to evaluate the potential diagnostic and prognostic value of GOLPH2.
Materials and Methods
Detailed procedures are provided in the Supplementary Materials and Methods (all supplemental materials can be found at American Journal of Clinical Pathology online).
Tissue Microarray Construction
Full ethical approval was granted by the School and Stomatology of Wuhan University Medical Ethics Committee (principal investigator: Zhi-Jun Sun) to use patient samples in this study. The specimens of the tissue microarrays were obtained from January 2008 to August 2015 at the Department of Oral and Maxillofacial Surgery, School and Hospital of Stomatology, Wuhan University. In the present study, all patients were diagnosed with OSCC by two independent pathologists. Clinical follow-up data, as annually assessed for survival time, were available for all patients. All information, including hospital records, histology slides, and pathology reports, was retrieved and reviewed. The clinical stage of the OSCC was classified according to the guidelines of the Union for International Cancer Control. 30 The grading scheme of the World Health Organization was used to determine the histologic grading. The OSCC cancer cohort consisted of 43 normal oral mucosae, 48 oral epithelial dysplasias, 165 patients with primary OSCC (excluding recurrent, presurgical inductive chemotherapy and presurgical radiotherapy), 12 patients with recurrent OSCC, 10 patients with OSCC who received presurgical radiotherapy (without presurgical chemotherapy), and 17 patients with OSCC who received presurgical TPF (docetaxel, cisplatin, and fluorouracil) inductive chemotherapy without presurgical radiotherapy by previous protocol. 31 Fortyone pathologically confirmed metastatic lymph nodes from 41 neck dissection specimens were constructed in the tissue microarray (TMA). Clinical features, including TNM stage, histologic grade, and overall survival, were available for all cases. Human papillomavirus (HPV) infection status was diagnosed by p16 immunostaining and the HPV DNA in situ hybridization technique.
Immunohistochemistry and Evaluation
The TMAs were performed on 4-μm-thick paraffin sections, which were then subjected to deparaffinization and rehydration. For epitope unmasking, the sections were boiled in 0.01 mol/L citric acid buffer solution (pH 6.0) for 1.5 minutes at high pressure. Then, the sections were blocked for endogenous peroxidase activity by incubating sections in 3% hydrogen peroxide solution for 20 minutes at room temperature, and 10% goat serum was added to the sections to block nonspecific binding. The TMAs were incubated overnight at 4˚C in a humidified chamber with primary antibody for GOLPH2 (1:500; GeneTex, San Antonio, TX), CD44 (1:100; Cell Signaling Technology, Danvers, MA), SOX2 (1:300; Cell Signaling Technology), Slug (1:200; Cell Signaling Technology), B7-H3 (1:800; Cell Signaling Technology), B7-H4 (1:800; Cell Signaling Technology), TIM3 (1:400; Cell Signaling Technology), VISTA (1:400; Cell Signaling Technology), or isotype-matched immunoglobulin G controls. A positive slide was created for each experiment. Subsequently, a secondary biotinylated IgG antibody solution and an avidin-biotin-peroxidase reagent were added to the slides. Peroxidase activity was detected with a 3,3′-diaminobenzidine solution. Then, the slides were counterstained by immersion in hematoxylin for 1 to 2 minutes. Slides were scanned by the ScanScope CS scanner (Aperio, Vista, CA) and then processed with background subtraction and white balance. The membrane, nuclear, or pixel immunohistochemical staining was quantified using Aperio Quantification software. For each sample, fields of high expression were scanned, and the membrane and nuclear immunostaining were calculated by the followed formula: (1 × percentage of weakly positive staining) + (2 × percentage of moderately positive staining) + (3 × percentage of strongly positive staining). Then, the scores were normalized between 0 and 300. The histoscores were converted to the range of -3 to 3 using Microsoft Excel (Microsoft, Redmond WA). Cluster 3.0 (Stanford University, Stanford, CA) with average linkage was used for hierarchical analysis, and the results were visualized using Java TreeView 1.1.3 (Stanford University).
Statistical Analysis
The data analyses were performed by GraphPad Prism version 5.0 for Windows (GraphPad Software, La Jolla, CA). One-way analysis of variance (ANOVA) followed by post-ANOVA Tukey multiple-comparison tests and unpaired t tests were used to analyze the differences among immunohistochemical staining within each group. The best cutoff of survival curves was calculated from the website Cutoff Finder (http://molpath.charite.de/cutoff/index.jsp) by a previously reported protocol. 32 The survival of the patients in the two groups was compared using a KaplanMeier analysis and log tests. Data were graphically represented as the mean values ± SEM. The Cox proportional hazards regression model was used for multivariate analysis to assess the significance of overall differences. The statistical significance level for all comparisons was set at P < .05.
Results

Expression of GOLPH2 in OSCC Is More Activated Than in Normal Mucosa and Dysplasia and Is Associated With Patient Survival
To determine whether overexpression of GOLPH2 was correlated with OSCC, the Oncomine database, a publicly available cancer data set, was used. In studies by Toruner et al 33 and Ginos et al, 34 messenger RNA (mRNA) expression indicated that the mRNA expression of GOLPH2 was significantly increased in OSCC compared with normal squamous cells (P < .005, Supplementary Figure 1) . Then, the tissue microarrays were used to evaluate the expression in OSCC tissues. Immunostaining revealed that cytoplasmic patterns of GOLPH2 staining were mainly found in the tumor cells, and partial expression was found in the stromal components ❚Figure 1A❚, which is consistent with a previous study about GOLPH2 expression in other types of cancer. [9] [10] [11] [12] [13] In addition, we detected that GOLPH2 had a stronger staining intensity in OSCC than in dysplasia (n = 43, P < .01) and in normal mucosae (n = 48, P < .005; ❚Figure 1B❚). Subsequently, we used Cutoff Finder to find the optimized cutoff by a previously reported protocol, 32 and a histoscore of 120.6 was calculated for the analysis as the best cutoff for survival. The Kaplan-Meier survival analysis in ❚Figure 1C❚ indicated that GOLPH2 expression was significantly correlated with poor overall survival in patients with OSCC at the best cutoff (P = .0005). When the median expression was used as the cutoff, a significant prognostic value for patient survival was not detectable, but a trend for longer survival times of patients with lower GOLPH2 expression was apparent in the Kaplan-Meier curve (Supplementary Figure 2E , P > .05). A multivariate Cox proportional hazard model using variables that included sex, age, pathologic grade, tumor size, lymph node stage, and GOLPH2 expression identified variables as prognostically significant by univariate analysis and demonstrated that high expression of GOLPH2 was a predictor of reduced survival (P = .034; ❚Table 1❚).
Expression of GOLPH2 in Metastatic Lymph Nodes Is Higher Than in Primary Tumor Tissue
We observed that GOLPH2 had a stronger immunoreactivity in metastatic lymph nodes than in primary tumor tissue ❚Figure 2A❚. The quantification also confirmed this result (P < .01; ❚Figure 2B❚). On further assessment, GOLPH2 was not significantly associated with pathologic grade (I, II, and III; P > .05; ❚Figure 2C❚). There was no significant difference in tumor size (T1 + T2 vs T3 + T4; P > .05; ❚Figure 2D❚) and lymph node metastasis status (N1 vs N2 + N3; P > .05; ❚Figure 2E❚), but we found a slight association from both parameters in the graph. Subsequently, no significant differences were observed for GOLPH2 expression from samples with different HPV infection status (P > .05; ❚Figure 2F❚). There was no significant correlation between GOLPH2 expression in primary OSCC and preoperation inductive TPF (P > .05; ❚Figure 2G❚), preoperation radiotherapy (P > .05; Supplementary Figure 2A) , and recurrent OSCC (P > .05; Supplementary Figure 2B) . Furthermore, no significant differences in GOLPH2 expression were observed for tobacco smoking (P > .05; Supplementary Figure 2C ) and alcohol consumption (P > .05; Supplementary Figure 2D ) in primary OSCC.
Protein Expression of GOLPH2 Was Conspicuously Associated With CD44, SOX2, Slug, B7-H3, B7-H4, TIM3, and VISTA in OSCC Tissue
We focused on specific antibody expression in human OSCC tissue microarrays. In previous studies, CD44, SOX2, Slug, B7-H3, B7-H4, TIM3, and VISTA had high expressions in OSCC compared with normal tissue. [26] [27] [28] [29] [35] [36] [37] As shown in ❚Figure 3A❚, higher expressions of these molecules were confirmed in our TMAs. Immunohistochemical staining showed that CD44 and SOX2, markers of CSCs, were overexpressed in tumor tissue ( Figure 3A) . Slug, an EMT marker, was overexpressed in the TMAs ( Figure 3A ). TIM3 and VISTA were highly expressed in the tumor-infiltrating immune cells in the tumor microenvironment ( Figure 3A ). B7-H3 and B7-H4 were highly expressed in the immune cells and tumor cells ( Figure 3A) . Hierarchical clustering further confirmed that GOLPH2 expression was closely associated with B7-H4 expression ❚Figure 3B❚. Interestingly, the Pearson correlation coefficient test revealed that GOLPH2
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❚Figure 1❚ Increased expression of Golgi phosphoprotein 2 (GOLPH2) in human oral squamous cell carcinoma (OSCC). A, Representative H&E and immunohistochemical staining of GOLPH2 in OSCC tissue compared with normal mucosa (×4 and ×20). B, Quantification of the immunohistochemical histoscore of GOLPH2 in oral squamous cell carcinoma (OSCC, n = 165) compared with dysplasia (DYS, n = 48) and oral mucosa (MUC, n = 43). C, Kaplan-Meier curve according to low (n = 136) and high (n = 29) expression of GOLPH2. The best cutoff (120.6) was used. *P < .01. **P < .001.
expression was statistically associated with CD44 (P < .0001, r = 0.3855), SOX2 (P = .0005, r = 0.2692), Slug (P = .0005, r = 0.2662), B7-H3 (P = .0006, r = 0.2635), B7-H4 (P < .0001, r = 0.5939), TIM3 (P < .0001, r = 0.4520), and VISTA (P = .0002, r = 0.2909) ❚Figure 4❚.
Discussion
In the present study, our results demonstrated that GOLPH2 was highly and aberrantly expressed in human primary OSCC tissue compared with dysplasia and normal mucosa. Furthermore, we observed GOLPH2 was more highly expressed in metastatic lymph nodes than in primary tumor tissue. Survival analysis indicated that patients with high GOLPH2 expression had poor overall survival compared with those with low GOLPH2 expression. In addition, the data in the present study demonstrated that the expression of GOLPH2 correlated with that of CD44, SOX2, Slug, B7-H3, B7-H4, TIM3, and VISTA. Our findings support that GOLPH2 may be a prognostic indicator for OSCC. To our knowledge, this is the first systematic study of GOLPH2 expression in OSCC in the clinical setting.
Cell invasion is a major feature of malignancy, and the Golgi apparatus plays an important role in cell migration and acts as a hub for different signaling pathways. 38 Therefore, elucidation of the regulatory networks of the Golgi apparatus will provide important information for the development of therapeutic strategies against cancer migration, invasion, and metastasis. GOLPH2, a cis-Golgi-localized protein with unknown cell function, is overexpressed and usually an indicator for poor prognosis in several types of cancer. [9] [10] [11] [12] [13] [14] Previous studies have indicated that GOLPH2 plays a role in regulating tumor cell migration and invasion, important functions for the metastatic process in many kinds of cancer. 14, 39, 40 A recent study 41 has shown that GOLPH2 promotes hepatocellular carcinoma invasion by the activation of matrix metalloproteinases (MMPs), which play a crucial role in degradation of basement membranes and the extracellular matrix. Furthermore, studies have proved that MMP molecules are correlated with OSCC metastasis. [42] [43] [44] Previous results have indicated that adhesion molecules such as CD44 are involved in positioning activated MMPs on the cell surface of invasive tumor cells. 45 A recent study confirmed that GOLPH2 expression leads to increased expression of EMT-related proteins and that GOLPH2 silencing reduces hepatocellular carcinoma cell migration in vitro. 40 Molecular profiling has shown that cancer cells and tumors that exhibit the CSC phenotype also express genes associated with the EMT. 46 In the present study, GOLPH2 expression was associated with CSC markers (CD44 and SOX2) and an EMT marker (SLUG). CSCs play an important role in tumor metastasis. CD44, a transmembrane glycoprotein and a key cell surface marker of CSCs in head and neck carcinoma, has possessed unique properties in functional assays for CSC self-renewal and differentiation. 47, 48 SOX2, which also has been recognized for causing "stemness" characteristics in cancer cells, can lead to cell immortality and account for the self-renewal and invasive properties of cancer cells. 49, 50 Slug, a C2H2-type zinc finger transcription factor that is also an EMT marker, has been identified in aggressive cancers. 51 Our data support this point, as GOLPH2 expression in the lymph nodes was higher than in primary OSCC tissue. Moreover, patients with higher GOLPH2 expression had shorter survival times compared with patients with lower GOLPH2 expression. This finding may reveal novel ways that GOLPH2 regulates tumor cell migration and invasion, important functions for the metastatic process in OSCC.
The immune system plays a crucial role in the carcinogenesis of OSCC. 24 The immune system can recognize and eliminate cancer, but it is held in check by inhibitory receptors and ligands. These immune checkpoint pathways, which normally maintain self-tolerance and limit collateral tissue damage during antimicrobial immune responses, can be coopted by cancer to evade immune destruction, particularly targeting T cells that are specific for tumor antigens. 52, 53 GOLPH2 overexpression attenuated antitumor Th1 lymphocyte response in a study on gastric cancer.
54 B7-H3, B7-H4, TIM3, and VISTA, which can act as inhibitory immune checkpoints, play an important role in carcinogenesis. 55 As shown in previous and present studies, these molecules have a high expression in OSCC. [26] [27] [28] [29] In the present study, we also showed that GOLPH2 expression was correlated with the expression of B7-H3, B7-H4, TIM3, and VISTA. Furthermore, we can detect close correlations between GOLPH2 and B7H4 from the cluster graph. In our previous study, higher expression of B7-H4 confers poor prognosis of patients with OSCC. 28 In our data, a similar result was found, with high expression of GOLPH2 signifying a poor prognosis. To our knowledge, this is the first report of GOLPH2 correlations with immune checkpoints.
Conclusion
Our study suggests that GOLPH2 is a novel predictive marker for clinical outcome in OSCC. Meanwhile, the positive correlation among GOLPH2 and CD44, SOX2, Slug, B7-H3, B7-H4, TIM3, and VISTA preliminarily identifies the GOLPH2-associated molecules that may play a potential role in tumor invasion and migration.
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❚Figure 2❚ Higher expression of Golgi phosphoprotein 2 (GOLPH2) in oral squamous cell carcinoma (OSCC) tissue than metastatic lymph nodes. A, A representative patient (patient 29) for whom the immunochemical histoscore was greater in OSCC tissue than in the metastatic lymph node (LN) (×4 and ×20). B, Histoscore of GOLPH2 in OSCC tissue (n = 165) compared with tissue of metastatic LNs (n = 41). *P < .01. C, Quantification of the immunohistochemical histoscore of GOLPH2 by pathologic grade (I, n = 43; II, n = 84; and III, n = 38). D, Quantification of immunochemical histoscore of GOLPH2 between T1 + T2 (n = 115) and T3 + T4 (n = 50). E, Quantification of the immunohistochemical histoscore of GOLPH2 between N1 (n = 105) and N2 + N3 (n = 60). F, Quantification of immunohistochemical histoscore of GOLPH2 between human papillomavirus (HPV)-positive (n = 16) and HPV-negative (n = 149) samples. G, Quantification of immunohistochemical histoscore of GOLPH2 in primary OSCC (n = 165) compared with preoperative inductive TPF (docetaxel, cisplatin, and fluorouracil) (n = 17). All data are presented as the means ± SEM. NS, not significant.
Because this is a small OSCC cohort, further study is still needed. Our data also provide evidence that GOLPH2 is a potential marker for estimating the patient's prognosis and may be a novel target for molecular-targeted therapy against OSCC. Functional studies are needed to evaluate the mechanisms involved. 
